Peer Review History
| Original SubmissionSeptember 25, 2025 |
|---|
|
Dear Dr. Fuentes, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. The comments from the reviewer can be found below. Please review these comments and make the appropriate revisions to your manuscript alongside a point-by-point response to the concerns raised. Please submit your revised manuscript by Sep 06 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Ilse Bloom Staff Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Thank you for the opportunity to review this manuscript. The topic addressed in this study is highly relevant and focuses on populations that are often underserved or overlooked. The use of a community based participatory research (CBPR) approach is particularly commendable, especially the meaningful involvement of participants as co researchers. The choice of Photovoice is also appropriate, as it allows the research team to capture not only observable realities but also the perspectives, emotions, and lived experiences of participants on a sensitive and important issue. The methodology is clearly articulated, and the detailed procedural descriptions greatly support the reader’s understanding of the project. The bibliography is strong and provides solid support for the conceptual and methodological choices made throughout the manuscript. I do, however, have several questions and suggestions for clarification that I believe will strengthen the manuscript. General Comments 1. Sample distribution and cultural influence on findings You mention that the sample reflects the population distribution of Pell’s residents, which is an important strength. However, given that the study’s findings will rely heavily on participants’ perceptions—often shaped by cultural norms, traditions, and community histories—I wonder how the demographic distribution (e.g., more than 50% South Asian participants, and a Black population twice the size of the Chinese population) might influence the results. Could this distribution affect the themes that emerge, and if so, how do you plan to account for or manage this in your analysis? 2. Knowledge translation activities The manuscript mentions conference presentations as part of the knowledge translation plan, but it is unclear whether peer reviewed publications are also planned. Will articles be produced from this study, and will co researchers be included as co authors or contributors? 3. Ethical approval While ethical considerations are addressed throughout the manuscript, it is not stated whether the study has been submitted to, or approved by, a research ethics committee. Please clarify the status of ethics approval. Specific Comments by Page Page 5 • Spell out Community Based Participatory Research (CBPR) at first mention. • At the end of the last paragraph: What are the characteristics of the individuals sitting on the Community Advisory Board (CAB)? Page 6 • First paragraph: Please clarify what qualifies someone as a “recent immigrant” in this context. • Study participants: Define what “complex care” entails for “caregivers of children with complex care needs.” • There is inconsistency between “caregivers OF children…” and “caregivers FOR children…” across sections. Please harmonize the phrasing. Page 7 • Second paragraph: Provide a brief explanation of the “maximum variation sampling approach” or include a reference. • Third paragraph: Specify the types of organizations that will be involved. Page 8 • First paragraph: The timeline indicates recruitment beginning in September 2025 and workshops starting in October 2025. Given the current date, this may need updating. Have these activities already taken place? • Third paragraph: o Regarding “co researchers may access online public domain images”: Will the research team provide these images or guidance on accessing them? I am concerned about the copyright issues. o Why don’t you consider including past oriented prompts to explore how participants perceive changes over time. o Clarify whether Workshops 1 and 2 occur within the same week. It is clearer for the other workshops. Page 11 • Last sentence: “Photovoice co facilitators will be available for meetings via Zoom, phone, or email.” As written, it suggests that meetings may occur via email. Consider rephrasing for clarity. Page 12 • In “Phase 2: Photovoice evaluation,” the text refers to four Photovoice workshop series, whereas the abstract and Table 1 mention six workshops. Please clarify this discrepancy. Page 14 • The end of the second paragraph in the Discussion and Conclusion suggests that this is the first phase of a larger research program. If this is the case, it would be helpful to state this clearly earlier in the manuscript, particularly when outlining the study objectives. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Charles Daboné ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Building Capacity in Health Systems with and for Caregivers: A Photovoice protocol PONE-D-25-48467R1 Dear Dr. Fuentes, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jennifer Annette Campbell Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-48467R1 PLOS One Dear Dr. Fuentes, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS One Editorial Office Staff on behalf of Dr. Jennifer Annette Campbell Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .